Osteogenic Differentiation Medium For Human Umbilical Cord Mesenchymal Stem Cells
Introduction
OriCell™ Osteogenic Differentiation Medium For Human Umbilical Cord Mesenchymal Stem Cells, developed by the OriCell™ R&D team, including a basic medium suitable for the growth of human umbilical cord mesenchymal stem cells, premium fetal bovine serum, and a supplement for osteogenic differentiation of umbilical cord mesenchymal stem cells.
This product is suitable for osteogenic induction and differentiation of human umbilical cord mesenchymal stem cells. Extensive cell culture data have demonstrated that this product can induce these cells to differentiate efficiently and stably into osteoblasts.
When citing our products in academic journals, please indicate "OriCell™ + Catalog Number, from Cyagen Biosciences (Guangzhou) Inc."
Product Information
| Components | Catalog Number | Volume |
| OriCell™ Basal Medium For Cell Culture | BLDM-03011 | 177 mL |
| OriCell™ Fetal Bovine Serum (Superior-Quality) | FBSSR-01021 | 20 mL |
| OriCell™ Supplement For Human Umbilical Cord Mesenchymal Stem Cells Osteogenic Differentiation | HUXUC-04021 | 3 mL |
| Alizarin Red S Solution (pH=5.1~5.3) | ALIR-10001 | 10 mL |
| Gelatin | GLT-11301 | 10 mL |
QC
- Pass the detection of bacteria, fungi, mycoplasma and endotoxins.
- Pass the detection of osmotic pressure and pH.
- Pass the detection of product quality.
Please refer to "COA" for details.
General Handing Principles
- Ensure that all equipment is kept clean and tidy.
- Standard operation method. Please operate according to the method described in the product manual.
- The ingredients should be properly stored in accordance with the storage conditions and used as soon as possible.
- If complete medium cannot be used in a short period of time, it should be prepared in batches according to the volume ratio of each component in the kit and stored in aliquots.
Product Stability and Storage Conditions
- All ingredients must be kept in dark place.
- The basal medium should be stored in a refrigerator at 4°C for a period of 1 year. Other components should be stored at -20°C for a period of 2 years.
- The prepared complete medium can be stored at 4°C for a period of 1 month. If the culture conditions are stable, the container has great sealing performance, and there is no alternation of hot and cold condition, the period of using can be appropriately extended, but not exceed 45 days.
- Please use all products within the expiration date. Expired ingredients may significantly affect the cell culture effect.
- Differentiation of Human Umbilical Cord Mesenchymal Stem Cells Into Steroidogenic Cells in vitro. 点击索取文献 ››
- Mesenchymal stem cell-conditioned medium promotes MDA-MB-231 cell migration and inhibits A549 cell migration by regulating insulin receptor and human epidermal growth factor receptor 3 phosphorylation. 点击索取文献 ››
- Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126. 点击索取文献 ››
- Effects of Storage Solutions on the Viability of Human Umbilical Cord Mesenchymal Stem Cells for Transplantation. 点击索取文献 ››
- Differentiation of human umbilical cord mesenchymal stem cells into steroidogenic cells in vitro. 点击索取文献 ››
- Human umbilical cord mesenchymal stem cell conditioned medium attenuates renal fibrosis by reducing inflammation and epithelial-to-mesenchymal transition via the TLR4/NF-κB signaling pathway in vivo and in vitro. 点击索取文献 ››
- Human umbilical cord mesenchymal stromal cells-derived extracellular vesicles exert potent bone protective effects by CLEC11A-mediated regulation of bone metabolism. 点击索取文献 ››
-
Differentiation of Human Umbilical Cord Mesenchymal Stem Cells Into Steroidogenic Cells in vitro.
Experimental and Therapeutic Medicine 12: 3527-3534 (2016) IF = 1.261 Year 2016
-
Mesenchymal stem cell-conditioned medium promotes MDA-MB-231 cell migration and inhibits A549 cell migration by regulating insulin receptor and human epidermal growth factor receptor 3 phosphorylation.
ONCOLOGY LETTERS 13:1581-1586 (2017) IF = 1.39 Year 2017
-
Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126.
Acta Biomaterialia PMID: 31857259 (2019) IF = 6.638 Year 2019
-
Effects of Storage Solutions on the Viability of Human Umbilical Cord Mesenchymal Stem Cells for Transplantation.
Cell Transplant 22: 1075 (2013) IF = 3.127 Year 2013
-
Differentiation of human umbilical cord mesenchymal stem cells into steroidogenic cells in vitro.
EXPERIMENTAL AND THERAPEUTIC MEDICINE 12:3527(2016) IF = 1.28 Year 2016
-
Human umbilical cord mesenchymal stem cell conditioned medium attenuates renal fibrosis by reducing inflammation and epithelial-to-mesenchymal transition via the TLR4/NF-κB signaling pathway in vivo and in vitro.
Stem Cell Res Ther 9: 7 (2018) IF = 4.963 Year 2018
-
Human umbilical cord mesenchymal stromal cells-derived extracellular vesicles exert potent bone protective effects by CLEC11A-mediated regulation of bone metabolism.
Theranostics 10: 2293-2308 (2020) IF = 8.063 Year 2020